International Journal of Pharma and Bio Sciences
    ISSN 0975-6299

Int J Pharm Bio Sci Volume 12 Issue 1, 2021 (January-March), Pages:59-65

Clinical Pharmacist as a Medication Therapy Specialist in the Management of Type-II Diabetes Mellitus

Pragya Pandey, Nilesh Sharma, Shambaditya Goswami, and Ravindra Pal Singh

In recent few years, diabetes mellitus has become one of the major high alarming health disasters which is accelerated with serious issues of mortality and morbidity. The paper aims to bring a critique of the ongoing corroboration for the role of pharmacists in diabetes care and clairvoyance into what roles pharmacists may carry out into forthcoming. A web-gleaned search viz. JAMA, PUBMED, ELSEVIER, RESEARCH GATE, GOOGLE scholar etc. and some research articles, review papers, conference proceedings, unpublished works were made available for a successful review. Pharmacists play a tremendous role in diabetes .Their main limelight is patient counselling. Patient counselling makes the patient to understand his/her illness, unavoidable life style modifications and the therapeutic approach in a preferable way. Pharmacists provide mandatory information, advice and assistance that helps the patients to take their medications properly. Not having important information can guide a patient mistakenly taking medicine, which may result in adverse reactions. Pharmacists are among the most accessible and trusted health care professionals. Elements like obesity, poor lifestyle can also lead to this disease. For the pharmacist, educating patients is one of the most far-reaching roles in society. Diabetes affects the most in our day to day life by de-escalating the health rank among patients. Presently, health care professionals have become more patient orientated only to show a high therapeutic effect for their patients. Counseling plans consider both pharmacological and non-pharmacological actions. The ultimate goal is to optimize the patient's quality of life. Patient counseling is the main source for achieving pharmaceutical care. The ultimate goal of pharmacists is to encourage the safe and secure use of medications. Clinical drug specialists through medication therapy management can deliver administrations by controlling, recognizing and checking drug related issues looked by the patients. This can contribute in diminishing the predominance of diabetes mellitus and improving the personal satisfaction.

Keywords: Role of clinical pharmacists, diabetes mellitus type 2, diagnosis of T2DM, general principles of diabetes, management of diabetes mellitus, oral antidiabetic drugs.
Full HTML:


1.       Hughes Jeffery David, Wibowo Yosi, Sunderland Bruce, Hoti Kreshnik. The role of the pharmacist in the management of type 2 diabetes: current insights and future directions. Integr Pharm Res Pract. Jan 2017;6:15-27. doi: 10.2147/IPRP.S103783, PMID 29354547.

2.       Tripathi K-D. Essentials of medical pharmacology. Jaypee Publications; 2019. p. 294-5.

3.       American Diabetes Association. Standards of care; 2016. 2017. doi: 10.2337/dc20-S002.

4.       Shaw Jonathan E, Sicree Richard A, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. Jan 2010;87(1):4-14. doi: 10.1016/j.diabres.2009.10.007, PMID 19896746.

5.       Guariguata Leonor, Whiting David, Weil Clara, Unwin Nigel. The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults. Diabetes Res Clin Pract. Dec 2011;94(3):322-32. doi: 10.1016/j.diabres.2011.10.040, PMID 22100977.

6.       Atkinson Mark A, Eisenbarth George S, Michels Aaron W. Type 1 diabetes. Lancet. Jan 2014;383(9911):69-82. doi: 10.1016/j.diabres.2011.10.040.

7.       Marshall Julie A, Hoag Sharon, Shetterly Susan, Hamman Richard F. Dietary fat predicts conversion from impaired glucose tolerance to NIDDM: the San Luis Valley Diabetes Study. Diabetes Care. Jan 1994;17(1):50-6. doi: 10.2337/diacare.17.1.50, PMID 8112189.

8.       Olokoba Abdulfatai B, Obateru Olusegun A, Olokoba Lateefat B. Type 2 diabetes mellitus: a review of current trends. Oman Med J. Jul 2012;27(4):269-73. doi: 10.5001/omj.2012.68, PMID 23071876.

9.       Kirkman MSue, Rowan-Martin Megan T, Levin Rebecca, Fonseca Vivian A, Schmittdiel Julie A, Herman William H, Aubert Ronald E. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care. Apr 2015;38(4):604-9. doi: 10.2337/dc14-2098, PMID 25573883.

10.     Dyson PA, Kelly Tracy, Deakin Trudi, Duncan Arlene, Frost Gary, Harrison Z, Khatri D, Kunka D, McArdle P, Mellor D, Oliver L, Worth J, Diabetes UK Nutrition Working Group. Diabetes UK evidence?based nutrition guidelines for the prevention and management of diabetes. Diabet Med. Nov 2011;28(11):1282-8. doi: 10.1111/j.1464-5491.2011.03371.x, PMID 21699560.

11.     Gillespie Kathleen M, Bain Steven C, Barnett Anthony H, Bingley Polly J, Christie Michael R, Gill Geoffrey V, Gale Edwin AM. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet. 2004 Nov 6;364(9446):1699-700. doi: 10.1016/S0140-6736(04)17357-1, PMID 15530631.

12.     Diabetes Control and Complications Trial Research Group. Hypoglycemia in the diabetes control and complications trial. Diabetes. 1997 Feb 1;46(2):271-86. doi: 10.2337/dc13-2112.

13.     Hanas Ragnar, John Garry, International HbA1c Consensus Committee. 2010 Consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Diabetes Care. 2010 Aug 1;33(8):1903-4. doi: 10.2337/dc10-0953, PMID 20519665.

14.     Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30;329(14):977-86. doi: 10.1056/NEJM199309303291401, PMID 8366922.

15.     Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. US Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care. 2000 May 1;23(5):639-43. doi: 10.2337/diacare.23.5.639, PMID 10834423.

16.     Boutati Eleni I, Raptis Sotirios A. Self-monitoring of blood glucose as part of the integral care of type 2 diabetes. Diabetes Care. 2009 Nov 1;32;Suppl 2:S205-10. doi: 10.2337/dc09-S312, PMID 19875553.

17.     American Association of Diabetes Educators. AADE guidelines for the practice of diabetes self-management education and training (DSME/T). The Diabetes Educator. 2009 Nov;35(3_suppl):85S-107S. doi: 10.2337/diaclin.34.2.70.

18.     American Association of Diabetes Educators. AADE7 self-care behaviors. Diabetes Educ. 2008;34(3):445-9. doi: 10.1177/0145721708316625, PMID 18535317.

19.     Pyorala K, Debacker G, Graham I, Poolewilson P, Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis. Oct 1994;110(2):121-61. doi: 10.1016/0021-9150(94)90200-3.

20.     Rastogi A. World diabetes day 2018. doi: doi; 2018. National health portal India (NHP). Available from:

21.     Pandey Suresh K, Sharma Vidushi. World diabetes day 2018: battling the emerging epidemic of diabetic retinopathy. Indian J Ophthalmol. 2018;66(11) Nov:1652-3. doi: 10.4103/ijo.IJO_1681_18, PMID 30355895.

22.     Armour Carol L, Taylor Susan J, Hourihan Fleur, Smith Carlene, Krass Ines. Implementation and evaluation of Australian pharmacists’ diabetes care services. J Am Pharm Assoc. 2004;44(4), Nov:455-66. doi: 10.1331/1544345041475625, PMID 15372866.

23.     Shareef Javedh, Fernandes Jennifer, Samaga L. Evolving role of clinical pharmacist in the management of diabetes mellitus. Int J Res Med Sci. Jun 2015:1305-8. doi: 10.18203/2320-6012.ijrms20150136.

24.     Hughes Jeffery David, Wibowo Yosi, Sunderland Bruce, Hoti Kreshnik. The role of the pharmacist in the management of type 2 diabetes: current insights and future directions. Integr Pharm Res Pract. 2017;6:15-27. doi: 10.2147/IPRP.S103783, PMID 29354547.

25.     Stolar Mark W. Insulin resistance, diabetes, and the adipocyte. Am J Health Syst Pharm. 2002;59(9);Suppl 9, Dec:S3-8. doi: 10.1093/ajhp/59.suppl_9.S3, PMID 12489380.

26.     Swain Jeannie H, Macklin Rose. Individualized diabetes care in a rural community pharmacy. J Am Pharm Assoc. 2001;41(3), May:458-61. doi: 10.1016/S1086-5802(16)31260-8, PMID 11372911.

27.     Klisic Aleksandra, Kavaric Nebojsa, Jovanovic Milovan, Zvrko Elvir, Skerovic Verica, Scepanovic Andjelka, Medin Darko, Ninic Ana. Association between unfavorable lipid profile and glycemic control in patients with type 2 diabetes mellitus. J Res Med Sci Off J Isfahan Univ Med Sci. 2017;22:122. doi: 10.4103/jrms.JRMS_284_17, PMID 29259633.

28.     Foster Nicole C, Beck Roy W, Miller Kellee M, Clements Mark A, Rickels Michael R, DiMeglio Linda A, Maahs David M, Tamborlane William V, Bergenstal Richard, Smith Elizabeth, Olson Beth A, Garg Satish K. State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther vol. 2019;21(2), Feb:66-72. doi: 10.1089/dia.2018.0384, PMID 30657336.

29.     McKnight JA, Wild SH, Lamb MJE, Cooper MN, Jones TW, Davis EA, Hofer S, Fritsch M, Schober E, Svensson J, Almdal T, Young R, Warner JT, Delemer B, Souchon PF, Holl RW, Karges W, Kieninger DM, Tigas S, Bargiota A, Sampanis C, Cherubini V, Gesuita R, Strele I, Pildava S, Coppell KJ, Magee G, Cooper JG, Dinneen SF, Eeg-Olofsson K, Svensson AM, Gudbjornsdottir S, Veeze H, Aanstoot HJ, Khalangot M, Tamborlane WV, Miller KM. Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015 Aug;32(8):1036-50. doi: 10.1111/dme.12676, PMID 25510978.

30.     Lyons Sarah K, Hermann Julia M, Miller Kellee M, Hofer Sabine E, Foster Nicole C, Rami-Merhar Birgit M, Aleppo Grazia, Seufert Jochen, DiMeglio Linda A, Danne Thomas, Maahs David M, Holl Reinhard W. Use of adjuvant pharmacotherapy in type 1 diabetes: international comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries. Diabetes Care. 2017 Oct 1;40(10):e139-40. doi: 10.2337/dc17-0403, PMID 28768688.

31.     Haynes Aveni, Hermann Julia M, Miller Kellee M, Hofer Sabine E, Jones Timothy W, Beck Roy W, Maahs David M, Davis Elizabeth A, Holl Reinhard W, T1D Exchange, WACDD and DPV registries. T1D Exchange, WACDD and DPV registries. Severe hypoglycemia rates are not associated with HbA1c: a cross?sectional analysis of 3 contemporary pediatric diabetes registry databases. Pediatr Diabetes. 2017 Nov;18(7):643-50. doi: 10.1111/pedi.12477, PMID 27878914.

32.     Miller Kellee M, Foster Nicole C, Beck Roy W, Bergenstal Richard M, DuBose Stephanie N, DiMeglio Linda A, Maahs David M, Tamborlane William V, T1D Exchange Clinic Network. Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015 Jun 1;38(6):971-8. doi: 10.2337/dc15-0078, PMID 25998289.

33.     Choe Hae Mi, Mitrovich Sonya, Dubay Daniel, Hayward Rodney A, Krein Sarah L, Vijan Sandeep. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care. 2005;11(4):253-60. PMID 15839185.

34.     Krass Ines, Mitchell B, Clarke P, Brillant M, Dienaar R, Hughes Jeffery, Lau P, Peterson G, Stewart K, Taylor S, Wilkinson J, Armour C. Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Res Clin Pract. Mar 2007;75(3):339-47. doi: 10.1016/j.diabres.2006.06.022, PMID 16884811.

35.     Pinto Sharrel L, Bechtol Robert A, Partha Gautam. Evaluation of outcomes of a medication therapy management program for patients with diabetes. J Am Pharm Assoc. Jul 2012;52(4):519-23. doi: 10.1331/JAPhA.2012.10098, PMID 22825233.

36.     Campbell R Keith. Role of the pharmacist in diabetes management. Am J Health Syst Pharm. Dec 2002;59(9);Suppl 9:S18-21. doi: 10.1093/ajhp/59.suppl_9.S18, PMID 12489383.

37.     Beckles Gloria LA, Engelgau Michael M, Narayan KM, Herman William H, Aubert Ronald E, Williamson David F. Population-based assessment of the level of care among adults with diabetes in the US. Diabetes Care. Sep 1998;21(9):1432-8. doi: 10.2337/diacare.21.9.1432, PMID 9727887.

38.     Peters Anne L, Legorreta Antonio P, Ossorio R Clifford, Davidson Mayer B. Quality of outpatient care provided to diabetic patients: a health maintenance organization experience. Diabetes Care. Jun 1996;19(6):601-6. doi: 10.2337/diacare.19.6.601, PMID 8725859.

39.     Dodds Seliece. The how-to for type 2: an overview of diagnosis and management of type 2 diabetes mellitus. Nurs Clin North Am. Dec 2017;52(4):513-22. doi: 10.1016/j.cnur.2017.07.002, PMID 29080574.

40.     Bhansali A, Dhandania VK, Deepa M, Anjana RM, Joshi SR, Joshi PP, Madhu SV, Rao PV, Subashini R, Sudha V, Unnikrishnan R, Das AK, Shukla DK, Kaur T, Mohan V, Pradeepa R. Prevalence of and risk factors for hypertension in urban and rural India: the ICMR–INDIAB study. J Hum Hypertens. 2015 Mar;29(3):204-9. doi: 10.1038/jhh.2014.57, PMID 25078490.

41.     Cohen D. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature. Pharmacopsychiatry. Jan 2004;37(1):1-11. doi: 10.1055/s-2004-815468, PMID 14750042.

42.     Wagner Edward H, Sandhu Nirmala, Newton Katherine M, McCulloch David K, Ramsey Scott D, Grothaus Louis C. Effect of improved glycemic control on health care costs and utilization. JAMA. Jan 2001;285(2):182-9. doi: 10.1001/jama.285.2.182, PMID 11176811.

43.     Raman-Wilms Lalitha. The pharmacist as patient educator. Can J Hosp Pharm. 2009 Mar;62(2):93-8. doi: 10.4212/cjhp.v62i2.436, PMID 22478873.

44.     Bakhshi M. Implementing foot care program in a Rural Clinic.

45.     Alkhawajah AM, Eferakeya AE. The role of pharmacists in patients’ education on medication. Public Health. 1992 May 1;106(3):231-7. doi: 10.1016/s0033-3506(05)80541-4, PMID 1603927.

46.     Smith Marie. Pharmacists’ role in improving diabetes medication management. J Diabetes Sci Technol. 2009 Jan;3(1):175-9. doi: 10.1177/193229680900300120, PMID 20046662.

47.     California HealthCare Foundation/American Geriatrics Society panel in improving care for elders with diabetes, care. "Guidelines for improving the care of the older person with diabetes mellitus." Journal of the American Geriatrics Society,May 2003;15(5s):265-80. doi: 10.4183/aeb.2019.311.

48.     Krass I, Stephenson S, I. Thuis, F. "Increasing adherence to medications through delivery of a disease management service for Type 2 diabetes in community pharmacies." J Soc Admin Pharm ,vol.19. 2002;6:211. doi: 10.2147/IPRP.S103783.

49.     Kerr Eve A, Heisler Michele, Krein Sarah L, Kabeto Mohammed, Langa Kenneth M, Weir David, Piette John D. Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients’ treatment priorities and self-management? J Gen Intern Med. Dec 2007;22(12):1635-40. doi: 10.1007/s11606-007-0313-2, PMID 17647065.

50.     Allen Larry A, Stevenson Lynne W, Grady Kathleen L, Goldstein Nathan E, Matlock Daniel D, Arnold Robert M, Cook Nancy R, Felker GMichael, Francis Gary S, Hauptman Paul J, Havranek Edward P, Krumholz Harlan M, Mancini Donna, Riegel Barbara, Spertus John A, American Heart Association, Council on Quality of Care and Outcomes Research, Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular Surgery and Anesthesia. ’Decision making in advanced heart failure: a scientific statement from the American Heart Association.’ Circulation vol. Circulation. Apr 2012;125(15):1928-52. doi: 10.1161/CIR.0b013e31824f2173, PMID 22392529.

51.     Huang Elbert S, Basu Anirban, O’Grady Michael, Capretta James C. Projecting the future diabetes population size and related costs for the US. Diabetes Care. Dec 2009;32(12):2225-9. doi: 10.2337/dc09-0459, PMID 19940225.

52.     Soule Jeremy B, Egede Leonard E. Challenges of managing diabetes in commercial truck drivers. Clin Diabetes. Jul 2007;25(3):110-1. doi: 10.2337/diaclin.25.3.110.

53.     Atlas. Diabetes. "International diabetes federation." IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015. doi: 10.1016/j.diabres.2017.03.024.

[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech Solutions
         Home I Contact I Terms & Conditions